Caption Management, LLC
Position in CRVS — Corvus Pharmaceuticals, Inc.
CIK 1706766
OKLAHOMA CITY, OK
Position in CRVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$956,667
+$956,667 QoQ
Shares Held
64,034
Ownership
0.076%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#77
of 172 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRVS Over Time
Shares Held
Position Value (USD)
Derivatives in CRVS
reported options exposure · as of Jun 30, 2026CallValue
$2,838,600
CallShares
190,000
PutValue
$1,664,316
PutShares
111,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Caption Management, LLC holds $249,760,911 across 78 Biotechnology names. CRVS ranks #45 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGON |
CG Oncology, Inc.
|
484,461 | $34,420,954 | |
| 2 | INSM |
INSMED Inc
|
236,000 | $25,162,320 | |
| 3 | ERAS |
Erasca, Inc.
|
1,041,225 | $19,075,242 | |
| 4 | CELC |
Celcuity Inc.
|
170,000 | $17,785,400 | |
| 5 | DSGN |
Design Therapeutics, Inc.
|
1,118,098 | $16,178,878 | |
| 6 | MLYS |
Mineralys Therapeutics, Inc.
|
413,087 | $11,145,087 | |
| 7 | REPL |
Replimune Group, Inc.
|
783,873 | $8,677,474 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
120,700 | $7,596,858 |
All Filings in CRVS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,838,600 | 190,000 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $1,664,316 | 111,400 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $956,667 | 64,034 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,340,800 | 160,000 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $815,430 | 105,900 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $379,802 | 49,325 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $192,500 | 25,000 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $160,864 | 21,827 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $87,308 | 21,827 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $159,000 | 50,000 | Call | Sole | 2025-05-15 | |
| 2024-12-31 | $3,376,920 | 631,200 | Call | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||